Anthem Biosciences Limited (NSE:ANTHEM)
India · Delayed Price · Currency is INR 656.25
-25.20 (-3.70%)
Mar 30, 2026, 3:30 PM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 368.56 billion as of March 31, 2026.
Market Cap
368.56B
Enterprise Value
359.34B
Revenue
20.02B
Ranking
n/a
PE Ratio
76.52
Stock Price
656.25
Market Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has decreased from 410.17B to 368.56B, a decrease of -10.15%. That is a compound annual growth rate of -14.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 368.56B | 0.73% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 598.96B |
| OneSource Specialty Pharma | 165.87B |
| Concord Biotech | 106.16B |
| Blue Jet Healthcare | 59.64B |
| Supriya Lifescience | 47.29B |
| Zota Health Care | 35.82B |
| Dishman Carbogen Amcis | 22.37B |
| Panacea Biotec | 19.59B |